Yahoo France Recherche Web

  1. Grâce à la mobilisation des donateurs, nous luttons chaque jour contre le cancer. Avec un don de 50€, vous offrez 1h d'activité physique adaptée pour les personnes malades.

  2. Soutenez nos projets de recherche sur le cancer pour sauver plus de vies. Bénéficiez d'une réduction d'impôt à hauteur de 66% du montant de votre don

Résultats de recherche

  1. MSK is a world-renowned cancer center that offers personalized treatment, groundbreaking research, and vital education programs. Find a doctor, location, or clinical trial near you, or donate to support MSK's mission of ending cancer for life.

    • Sloan Kettering Institute

      For more than 70 years, the Sloan Kettering Institute (SKI)...

    • Careers

      Let’s change the way the world treats cancer. Our...

    • MSK Direct

      A national cancer benefits solution. MSK Direct provides...

    • See The Ranking

      For more than three decades, U.S. News & World Report has...

  2. Le Memorial Sloan-Kettering Cancer Center ou MSKCC est un centre de traitement et de recherche sur le cancer fondé en 1884 en tant que New York Cancer Hospital à New York aux États-Unis.

  3. Memorial Sloan Kettering Cancer Center (MSK or MSKCC) is a cancer treatment and research institution in Manhattan in New York City. It was founded in 1884 as the New York Cancer Hospital. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers.

  4. Learn how Memorial Sloan Kettering diagnoses and treats cancer with a personalized approach. Find out about cancer types, risk assessment, clinical trials, and patient education.

  5. At Memorial Sloan Kettering, we believe that immunotherapy is one of the most promising ways to treat, cure, and ultimately prevent cancer. Immunotherapy was born at MSK more than a century ago. Since then our scientists have led the effort to develop new immune-based treatments for cancer.

    • Memorial Sloan-Kettering Cancer Center1
    • Memorial Sloan-Kettering Cancer Center2
    • Memorial Sloan-Kettering Cancer Center3
    • Memorial Sloan-Kettering Cancer Center4
    • Memorial Sloan-Kettering Cancer Center5
  6. IMPLICATIONS FOR PRACTICE: Identification of fibroblast growth factor receptor (FGFR) aberrations in cholangiocarcinoma and bladder cancer led to development of selective FGFR inhibitors for these indications, based on clinical benefit and safety profiles. The most frequent adverse events (AEs) include those affecting skin, hair, and nails, a ...

  7. 30 juin 2021 · Given the medical complexity and fragility of patients with endometrial carcinoma, further characterization of adverse reactions (ARs) associated with treatment will help health care professionals to optimize treatment with lenvatinib plus pembrolizumab combination therapy.